Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica KSM van der Geest, WH Abdulahad, P Chalan, A Rutgers, G Horst, ... Arthritis & Rheumatology 66 (7), 1927-1938, 2014 | 144 | 2014 |
Aging disturbs the balance between effector and regulatory CD4+ T cells KSM van der Geest, WH Abdulahad, SM Tete, PG Lorencetti, G Horst, ... Experimental gerontology 60, 190-196, 2014 | 137 | 2014 |
Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica KSM van der Geest, WH Abdulahad, A Rutgers, G Horst, J Bijzet, ... Rheumatology 54 (8), 1397-1402, 2015 | 133 | 2015 |
Different scoring methods of FDG PET/CT in giant cell arteritis: need for standardization MD Stellingwerff, E Brouwer, KJDF Lensen, A Rutgers, S Arends, ... Medicine 94 (37), e1542, 2015 | 131 | 2015 |
Diagnostic accuracy of symptoms, physical signs, and laboratory tests for giant cell arteritis: a systematic review and meta-analysis KSM van der Geest, M Sandovici, E Brouwer, SL Mackie JAMA internal medicine 180 (10), 1295-1304, 2020 | 109 | 2020 |
Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia KSM van der Geest, F Borg, A Kayani, D Paap, P Gondo, W Schmidt, ... Annals of the Rheumatic Diseases 79 (3), 393-399, 2020 | 104 | 2020 |
Diagnostic value of [18F] FDG-PET/CT for treatment monitoring in large vessel vasculitis: a systematic review and meta-analysis KSM van der Geest, G Treglia, AWJM Glaudemans, E Brouwer, ... European journal of nuclear medicine and molecular imaging 48 (12), 3886-3902, 2021 | 77 | 2021 |
What is the current evidence for disease subsets in giant cell arteritis? KSM van der Geest, M Sandovici, Y van Sleen, JS Sanders, NA Bos, ... Arthritis & rheumatology 70 (9), 1366-1376, 2018 | 72 | 2018 |
Involvement of monocyte subsets in the immunopathology of giant cell arteritis Y van Sleen, Q Wang, KSM van der Geest, J Westra, WH Abdulahad, ... Scientific reports 7 (1), 6553, 2017 | 60 | 2017 |
Diagnostic value of [18F] FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis KSM van der Geest, G Treglia, AWJM Glaudemans, E Brouwer, F Jamar, ... European journal of nuclear medicine and molecular imaging 48, 1876-1889, 2021 | 58 | 2021 |
Markers of angiogenesis and macrophage products for predicting disease course and monitoring vascular inflammation in giant cell arteritis Y van Sleen, M Sandovici, WH Abdulahad, J Bijzet, KSM van der Geest, ... Rheumatology 58 (8), 1383-1392, 2019 | 58 | 2019 |
Distinct macrophage phenotypes skewed by local granulocyte macrophage colony‐stimulating factor (GM‐CSF) and macrophage colony‐stimulating factor (M‐CSF) are associated with … WF Jiemy, Y van Sleen, KSM van der Geest, HA Ten Berge, ... Clinical & translational immunology 9 (9), e1164, 2020 | 50 | 2020 |
Leukocyte dynamics reveal a persistent myeloid dominance in giant cell arteritis and polymyalgia rheumatica Y Van Sleen, JC Graver, WH Abdulahad, KSM Van der Geest, AMH Boots, ... Frontiers in Immunology 10, 459855, 2019 | 50 | 2019 |
Circulating CD4+ CD161+ T lymphocytes are increased in seropositive arthralgia patients but decreased in patients with newly diagnosed rheumatoid arthritis P Chalan, BJ Kroesen, KSM van der Geest, MG Huitema, WH Abdulahad, ... PloS one 8 (11), e79370, 2013 | 47 | 2013 |
Quantifying Distribution of Flow Cytometric TCR-Vβ Usage with Economic Statistics KSM van der Geest, WH Abdulahad, G Horst, PG Lorencetti, J Bijzet, ... PloS one 10 (4), e0125373, 2015 | 41 | 2015 |
Towards precision medicine in ANCA-associated vasculitis KSM van der Geest, E Brouwer, JS Sanders, M Sandovici, NA Bos, ... Rheumatology 57 (8), 1332-1339, 2018 | 40 | 2018 |
A Distinct Macrophage Subset Mediating Tissue Destruction and Neovascularization in Giant Cell Arteritis: Implication of the YKL‐40/Interleukin‐13 Receptor α2 Axis Y Van Sleen, WF Jiemy, S Pringle, KSM Van der Geest, WH Abdulahad, ... Arthritis & Rheumatology 73 (12), 2327-2337, 2021 | 37 | 2021 |
SF Treg cells transcribing high levels of Bcl-2 and microRNA-21 demonstrate limited apoptosis in RA KSM Van Der Geest, K Smigielska-Czepiel, JA Park, WH Abdulahad, ... Rheumatology 54 (5), 950-958, 2015 | 35 | 2015 |
Decreased expression of negative immune checkpoint VISTA by CD4+ T cells facilitates T helper 1, T helper 17, and T follicular helper lineage differentiation in GCA R Hid Cadena, RD Reitsema, MG Huitema, Y Van Sleen, ... Frontiers in immunology 10, 466129, 2019 | 34 | 2019 |
Impact of aging on the frequency, phenotype, and function of CD161-expressing T cells KSM Van der Geest, BJ Kroesen, G Horst, WH Abdulahad, E Brouwer, ... Frontiers in immunology 9, 325765, 2018 | 34 | 2018 |